LAL (Limulus Amoebocyte Lysate) Test

LAL (Limulus Amoebocyte Lysate) Test

LAL (Limulus Amoebocyte Lysate) Test

LAL test is an in vitro test used to detect and measure bacterial endotoxins. It is a quality control test required by FDA for all parenteral drugs in their final stages of formulation.

Reagents:
Amoebocyte Lysate from horse shoe crab,  Limulus polyphemus.

Principle:
1. The test is based on blood clotting reaction of horse shoe crab.
2. The LAL reagent is derived from blood cells (amoebocytes) of a horse shoe crab.
3. The blood cells are separated from the serum using centrifugation and are than placed in distilled water, which causes them to swell up and burst or lyse.
4. This lysis of the cells releases chemicals called lysate that is purified and freeze-dried.
5. To test a sample for endotoxin detection the sample is mixed with lysate and water, if coagulation occurs endotoxins are present.
6. The rate of reaction depends upon concentration of endotoxins, pH, temperature.

Procedure:
1. Equipments should be depyrogenated.
2. Equal volume of LAL reagent and test solution (0.1 ml) are mixed in a test tube.
3. Incubation at 37 ℃ for 1 hour.
4. Remove the tube, invert in one smooth motion (180 degree) and observe the result.

Methods used:
1. Gelclot method - gel formation.
2. Turbidimetric - the turbidity occurs.
3. Chromogenic method - the development of color after cleavage of a synthetic peptide chromogen complex.

Application:
1. To diagnose urinary tract infections and spinal meningitis.
2. To assess food spoilage, air and water quality.
3. To determine the ability of new drugs to neutralise toxic effects.
4. Raw materials, solutions, biological products are tested.

Limitations:
1. LAL test cannot discriminate between living and dead bacteria.

2. Cannot differentiate species of bacterial endotoxins.


The Daily Youth- tdy24.com Presents
"LAL (Limulus Amoebocyte Lysate) Test"
Written By
Sadia Akhtar
Student of Department of Microbiology
Jagannath University.
Email- sadiabd810@yahoo.com

Post a Comment

0 Comments